CoralGenix Bio harnesses Florida’s unique marine biodiversity to develop groundbreaking therapeutics from coral-derived compounds and reef-inspired biomaterials. Headquartered in Miami, the company creates anti-inflammatory and tissue-regeneration drugs with applications in wound healing, arthritis, and neurodegenerative disease. Following successful preclinical results, CoralGenix raised $4.1 million under the Florida Invest Local Act in 2026 exclusively from Florida investors. This innovative biotech is accelerating toward IND filing and positioning the Sunshine State as a global leader in blue biotechnology 4.1M Invest Local Under Florida Exempition | Marine Biotech Therapeutics | Miami, FL | 2025
CoralGenix B
Saint Petersburg, FL
CoralGenix Bio harnesses Florida’s unique marine biodiversity to develop groundbreaking ... Read More
ENDS IN: 193 DAYS
capital goal